SCHEMBL13620651

SCHEMBL13620651

COc1ccc(C=O)cc1OCCc1cccc(C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
LMNA P02545 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
HTT P42858 1/20 0.57
FDPS P14324 1/20 0.57
ALDH1A1 P00352 6/20 0.53
TSHR P16473 1/20 0.53
ALOX5 P09917 1/20 0.52
HPGD P15428 4/20 0.51
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
PDCD1 Q15116 1/20 0.48
CD274 Q9NZQ7 1/20 0.48
LPAR1 Q92633 3/20 0.48
CYP2C9 P11712 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6229249 0.87 FDPS (0.63) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL18873955 0.86 MAOA (0.53) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL18874197 0.85 MAOA (0.50) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL13620624 0.84 FDPS (0.53) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL19242996 0.82 FDPS (0.73) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL18874317 0.82 FDPS (0.51) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL28653547 0.82 ALDH1A1 (0.74) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL13620714 0.81 MAOB (0.47) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL9078005 0.81 FDPS (0.72) MAPTSMN1; SMN2LMNANPSR1HTT
SCHEMBL31331562 0.81 FDPS (0.72) MAPTSMN1; SMN2LMNANPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303270-B1 ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-05-17 EP disclosed
WO-2009135590-A1 ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI-AVENTIS (FR) 2009-11-12 WO disclosed